These findings align with KEGG enrichment analysis, which identified AKT1, BDNF, TP53, GSK3βser9, and HIF1A as pivotal regulators of the Neurotrophin, PI3K-AKT, and Alzheimer’s disease pathways. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.